ICON Controls Pvt Revenue and Competitors

Delhi, IND

Location

N/A

Total Funding

Industrial

Industry

Estimated Revenue & Valuation

  • ICON Controls Pvt's estimated annual revenue is currently $8.7M per year.(i)
  • ICON Controls Pvt's estimated revenue per employee is $158,850

Employee Data

  • ICON Controls Pvt has 55 Employees.(i)
  • ICON Controls Pvt grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.1M70-39%N/AN/A
#2
$29.3M1519%N/AN/A
#3
$15M8515%N/AN/A
#4
$8.7M5557%N/AN/A
#5
$180.6M7318%N/AN/A
#6
$16.6M94-7%N/AN/A
#7
$331.1M13407%N/AN/A
#8
$16.1M916%N/AN/A
#9
$11.1M7015%N/AN/A
#10
$28M14416%N/AN/A
Add Company

What Is ICON Controls Pvt?

ICON Controls is a leading Turnkey solution provider for Electrical, Instrumentation and Automation solutions for various process Industries. ICON has provided solutions to almost all process industries like Oil & Gas, Refineries, Petrochemicals, Fertilizers, Steel, Power, Paper, Cement, Pharma, Water & Waste Water and Sugar Industries. A quality and time conscious company, ICON is managed by qualified professionals with decades of experience and depth of expertise in various process verticals. ICON specializes in speedy execution of turnkey projects right from design, detail engineering to procurement, manufacturing, testing, installation, commissioning and servicing. It's supported by project management skills & experience and complemented by proven standards of ISO 9001:2008 and Enterprise software Systems like ERP. Overseas, ICON has provided services in Dubai, Abu Dhabi, Nigeria, Bangladesh, Thailand & Indonesia.

keywords:N/A

N/A

Total Funding

55

Number of Employees

$8.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ICON Controls Pvt News

2022-04-06 - Effectiveness of COVID-19 mRNA Vaccination in Preventing ...

Case- and control-patients were demographically similar, with fewer underlying ... p-values <0.05 were considered statistically significant.

2022-03-22 - Effectiveness of Homologous and Heterologous COVID-19 ...

Nicola P. Klein reports institutional support from Pfizer, Merck, ... and control-patients without acute laboratory-confirmed COVID-19.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.2M5549%N/A
#2
N/A5637%N/A
#3
$13.6M5610%N/A
#4
$6.7M57-22%N/A
#5
$7.4M57-15%N/A